Connect Sign In
Erik Forsman, a senior data consultant for ARUP Healthcare Advisory Services, has published a new article in The Journal of Applied Laboratory Medicine to share the benefits of in-house data systems.
For 20-plus years, Mark Withers had inexplicable episodes of a severe anaphylaxis-like phenomenon. ARUP’s unique expertise and highly sensitive tests help patients like him find the right diagnosis.
As respiratory viruses cocirculate this season, laboratory testing is increasingly essential to inform treatment of children, older adults, and other vulnerable populations.
Successful stewardship relies on good governance, and in a new article, ARUP Senior Healthcare Consultant Tony Smith details how labs can leverage their expertise to better meet stewardship goals.
Efforts to train more medical laboratory scientists have been greatly boosted by $3 million in federal funds for a clinical lab training center that ARUP will build with the University of Utah.
The U.S. Food and Drug Administration (FDA) has updated its guidelines to allow individuals who lived or worked in the United Kingdom, France, or Ireland to donate blood and platelets.
ARUP Consult Provides New Resources on Multiple Sclerosis, Minimal Residual Disease, and Mumps Virus
ARUP Consult, a free source of expert guidance in laboratory testing, has released new and updated educational resources for multiple sclerosis, minimal residual disease, and mumps virus.
New ARUP Resource Simplifies Laboratory Testing Decisions for Clinicians Treating Multiple Sclerosis
A new ARUP Consult tool helps clarify the testing requirements for medication management when clinicians are treating patients with multiple sclerosis.
Laboratory-developed tests made up only about 4% of an academic health system’s total test orders in 2021, yet they played an important role in patient care, a new study shows.
ARUP Consult, a free source of expert guidance in laboratory testing, has updated educational resources for venous thromboembolism, cytomegalovirus, and hemoglobinopathies.
ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year.
Routine monitoring of patients taking direct factor Xa inhibitors is not required, but the efficacy and safety of this treatment can be measured with ARUP’s newest test offerings.
